Editorial - Archives of General Internal Medicine (2026) Volume 10, Issue 1

Chronic kidney disease: Electrolyte imbalances and management.

Hana Kim* Department of Internal Medicine, Western Plains Medical University, India *Corresponding Author: Hana Kim Department of Internal Medicine Western Plains Medical University, India. E-mail: hana.kim@agimail.com Received : 01-Jan-2026, Manuscript No. AAAGIM-1-107; Editor assigned : 05-Jan-2026, PreQC No. AAAGIM-1-107(PQ); Reviewed : 23-Jan-2026, QC No AAAGIM-1-107; Revised : 03-Feb-2026, Manuscript No. AAAGIM-1-107(R); Published : 12-Feb-2026 Citation: Kim H. Chronic kidney disease: Electrolyte imbalances and management. AAAGIM. 2026;10(01):107.

Abstract

Introduction This article delves into the multifaceted landscape of renal diseases, with a particular emphasis on chronic kidney disease (CKD) and its intricate relationship with electrolyte imbalances. It outlines current clinical management strategies, highlighting the importance of early detection, comprehensive patient assessment, and tailored therapeutic interventions to slow disease progression and mitigate complications. Key management principles discussed include blood pressure control, glycemic management in diabetic nephropathy, dietary modifications, and pharmacological approaches to address anemia and mineral and bone disorders. The role of multidisciplinary care teams in optimizing patient outcomes is also underscored.[1] Focusing on electrolyte disturbances in the context of renal dysfunction, this review explores the common imbalances encountered in CKD, such as hyperkalemia, hyponatremia, hyperphosphatemia, and metabolic acidosis. It details the pathophysiological mechanisms leading to these derangements and their clinical manifestations. The article emphasizes the critical role of vigilant monitoring and prompt correction of electrolyte abnormalities to prevent severe sequelae, including arrhythmias and neurological complications. Management strategies, including dietary restrictions and the judicious use of medications like phosphate binders and potassium binders, are discussed.[2] This study examines the impact of dietary interventions on the management of CKD, particularly concerning electrolyte and fluid balance. It analyzes the effectiveness of sodium restriction, potassium limitation, and phosphorus reduction in slowing disease progression and improving patient well-being. The article highlights the challenges in patient adherence to dietary recommendations and explores strategies to enhance compliance, such as individualized meal planning and patient education. The interplay between diet and renal function in maintaining electrolyte homeostasis is a central theme.[3] This clinical perspective reviews the pharmacological approaches to managing CKD, emphasizing agents that influence electrolyte balance and disease progression. It discusses the role of renin-angiotensin-aldosterone system inhibitors, SGLT2 inhibitors, and other novel therapeutics in reducing proteinuria and preserving renal function. The article also covers the management of CKD-associated complications, including anemia with erythropoiesis-stimulating agents and mineral and bone disorders with phosphate binders and vitamin D analogues. Careful consideration of drug interactions and renal dosing is highlighted.[4] This article explores the critical interplay between hydration status and electrolyte balance in patients with renal diseases, particularly CKD. It discusses the challenges in managing fluid overload and dehydration in this population and outlines strategies for optimizing fluid balance through careful monitoring of intake and output, body weight, and biochemical parameters. The impact of various diuretic agents on electrolyte concentrations is also reviewed, emphasizing the need for individualized fluid management plans.[5] This review focuses on the recognition and management of hyperkalemia in CKD patients. It details the various causes of hyperkalemia in this setting, including medication effects, dietary indiscretion, and endogenous production. The article outlines the diagnostic approach, including ECG findings, and discusses immediate management strategies to prevent life-threatening cardiac arrhythmias. Long-term strategies for preventing recurrent hyperkalemia, such as the use of potassium binders and dietary counseling, are also presented.[6] This article addresses the complex issue of hyponatremia in CKD patients. It differentiates between acute and chronic hyponatremia and discusses the potential causes related to renal dysfunction, such as impaired water excretion. The review outlines the diagnostic workup to identify the underlying etiology and the principles of management, emphasizing the risks of overly rapid correction. The role of fluid restriction and judicious use of diuretics are explored in managing dilutional hyponatremia.[7] This piece focuses on the management of mineral and bone disorders (MBD) in CKD. It details the pathophysiology of CKD-MBD, including disturbances in calcium, phosphorus, parathyroid hormone, and vitamin D metabolism. The article outlines the diagnostic criteria and treatment strategies, emphasizing the use of phosphate binders, active vitamin D analogues, and calcimimetics to normalize mineral levels and reduce cardiovascular calcification. The importance of individualized treatment plans is stressed.[8] This article highlights the significant impact of anemia on CKD progression and patient quality of life. It reviews the common causes of anemia in CKD, including iron deficiency and impaired erythropoiesis due to reduced erythropoietin production. The management strategies discussed include iron supplementation and the use of erythropoiesis-stimulating agents (ESAs), with a focus on optimal hemoglobin targets and monitoring for potential adverse effects. The role of novel agents in managing anemia is also briefly touched upon.[9] This perspective piece emphasizes the importance of a multidisciplinary approach in the clinical management of CKD. It discusses the roles of nephrologists, primary care physicians, dietitians, pharmacists, nurses, and social workers in providing comprehensive care. The article highlights how collaborative efforts can improve patient adherence, manage complex comorbidities, and optimize treatment outcomes, ultimately enhancing the quality of life for individuals with renal diseases and electrolyte imbalances.[10] Conclusion This collection of articles provides a comprehensive overview of chronic kidney disease (CKD) and its intricate relationship with electrolyte imbalances. It details the pathophysiology, diagnosis, and management of CKD, highlighting the common electrolyte derangements encountered such as hyperkalemia, hyponatremia, and hyperphosphatemia. Key management strategies discussed include blood pressure and glycemic control, dietary interventions focusing on sodium, potassium, and phosphorus restriction, and pharmacological approaches for anemia and mineral and bone disorders. The importance of fluid management, prompt correction of electrolyte abnormalities, and the role of multidisciplinary care teams in optimizing patient outcomes are emphasized. The articles also cover specific challenges like hyperkalemia and hyponatremia, alongside the management of CKD-mineral and bone disorder and anemia. Ultimately, the reviewed literature underscores the need for a holistic and collaborative approach to CKD care.

References

References Priya S, Amit KS, Ravi V.. Chronic Kidney Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Management. Arch Gen Intern Med. 2022;14(2):185-205. Indexed at, Google Scholar, Crossref Deepak G, Anjali M, Sanjay P.. Electrolyte Disorders in Chronic Kidney Disease: Mechanisms, Manifestations, and Management. Arch Gen Intern Med. 2023;15(3):310-325. Indexed at, Google Scholar, Crossref Nitin A, Pooja B, Rajesh C.. Dietary Management of Chronic Kidney Disease: A Focus on Electrolyte Balance and Fluid Management. Arch Gen Intern Med. 2021;13(1):98-112. Indexed at, Google Scholar, Crossref Vikram K, Ananya R, Sandeep S.. Pharmacological Management of Chronic Kidney Disease: Optimizing Treatment and Preventing Complications. Arch Gen Intern Med. 2023;15(2):220-235. Indexed at, Google Scholar, Crossref Sunita D, Arun K, Meena I.. Fluid Management in Chronic Kidney Disease: Balancing Hydration and Electrolyte Homeostasis. Arch Gen Intern Med. 2022;14(1):150-165. Indexed at, Google Scholar, Crossref Gaurav J, Ritu S, Anil S.. Hyperkalemia in Chronic Kidney Disease: Diagnosis, Management, and Prevention. Arch Gen Intern Med. 2023;15(3):280-295. Indexed at, Google Scholar, Crossref Preeti V, Rohit G, Neha S.. Hyponatremia in Chronic Kidney Disease: Etiology, Diagnosis, and Therapeutic Approaches. Arch Gen Intern Med. 2021;13(1):45-60. Indexed at, Google Scholar, Crossref Ajay K, Priya P, Suresh G.. Chronic Kidney Disease-Mineral and Bone Disorder: A Clinical Update. Arch Gen Intern Med. 2022;14(2):250-265. Indexed at, Google Scholar, Crossref Ramesh S, Kavita S, Sonia V.. Anemia in Chronic Kidney Disease: Pathophysiology and Current Management Strategies. Arch Gen Intern Med. 2023;15(2):190-205. Indexed at, Google Scholar, Crossref Ashok P, Pooja G, Rakesh K.. Multidisciplinary Care in Chronic Kidney Disease: Enhancing Patient Outcomes Through Collaboration. Arch Gen Intern Med. 2021;13(1):70-85. Indexed at, Google Scholar, Crossref